| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/17/1996 | EP0706802A2 A method of preserving ophthalmic solutions and compositions therefor |
| 04/17/1996 | EP0706795A2 Catechol diether compounds as inhibitors of TNF release |
| 04/17/1996 | EP0706394A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 04/16/1996 | US5508419 Substituted triazoles as angiotensin II inhibitors |
| 04/16/1996 | US5508405 Quinuclidines, their use as medicaments and processes for their preparation |
| 04/16/1996 | US5508300 Inhibit phosphodiesterase and production of tumor necrosis factor; treating inflammatory diseases |
| 04/11/1996 | WO1996010575A1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 04/11/1996 | WO1996010574A1 Method for preparing concentrated biologically active silicon compounds |
| 04/11/1996 | WO1996010571A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES |
| 04/11/1996 | WO1996005838A3 Combined preparation for the therapy of immune diseases |
| 04/10/1996 | EP0705266A1 Process for producing imidazole derivative |
| 04/10/1996 | CN1120339A New prednisolone derivates |
| 04/10/1996 | CN1120337A Process for production of an imidazole derivative |
| 04/10/1996 | CN1120038A Substituted ester of piperidine-1-alcohol, preparation and pharmaceutical use of same |
| 04/10/1996 | CN1119944A Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither |
| 04/09/1996 | US5506243 Sulfonamide derivatives |
| 04/09/1996 | US5506242 Arylsufonamido-substituted hydroxamic acids |
| 04/09/1996 | US5506240 Hypotensive agents |
| 04/09/1996 | US5506220 Derivatives of 17-alpha-hydroxy-3,20-dioxo-19-norpregna-4-ene |
| 04/09/1996 | US5505945 Method and compositions for the direct concentrated delivery of passive immunity |
| 04/04/1996 | WO1996009828A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 04/03/1996 | EP0703902A1 Piperidine derivatives and process for their production |
| 04/03/1996 | EP0703897A1 Lipoxin compounds |
| 04/03/1996 | EP0426714B1 Acetylenic imidazoles having central nervous system activity |
| 04/03/1996 | CN1119866A Enantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno|2,3-b¨thiopyran-2-sulfonamide 7,7-dioxide and related compounds |
| 04/03/1996 | CN1119861A 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 04/02/1996 | US5504080 Benzo-fused lactams |
| 04/02/1996 | US5503848 Topical dose of sterile, slow-release, lyophilized non-crosslinked hyaluronic acid ester; wound healing agents, ears |
| 03/28/1996 | WO1996009297A1 Compositions and methods for treating mast-cell inflammatory condition |
| 03/28/1996 | WO1996009063A1 Use of muramyl peptide compounds |
| 03/28/1996 | WO1996009054A1 Method and means for prevention and treatment of secondary cataract |
| 03/28/1996 | WO1996009044A1 Compositions useful for the preparation of medicines for treating a variety of intractable disorders |
| 03/28/1996 | CA2200570A1 Use of muramyl peptide compounds |
| 03/28/1996 | CA2200561A1 Compositions and methods for treating mast-cell inflammatory conditions |
| 03/27/1996 | EP0703218A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists |
| 03/27/1996 | EP0702681A1 Spiro-substituted azacycles as neurokinin antagonists |
| 03/27/1996 | EP0702680A1 2-oxo-1,2,3,4-tetrahydroquinoline derivatives |
| 03/27/1996 | EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 03/26/1996 | US5502075 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents |
| 03/26/1996 | US5502052 Use of a combination of apraclonidine and timolol to control intraocular pressure |
| 03/26/1996 | US5501856 Controlled-release pharmaceutical preparation for intra-ocular implant |
| 03/21/1996 | WO1996008480A1 Neurokinin antagonists |
| 03/21/1996 | WO1996008275A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 03/21/1996 | CA2200083A1 Neurokinin antagonists |
| 03/21/1996 | CA2199746A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 03/20/1996 | EP0702013A2 Imidazopyridines |
| 03/20/1996 | EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists |
| 03/20/1996 | EP0701565A1 New prednisolone derivates |
| 03/20/1996 | EP0701554A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 03/20/1996 | EP0701443A1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 03/20/1996 | EP0701438A1 Gaba-ergic modulation of eye growth |
| 03/20/1996 | EP0701434A1 Preparations containing silicon dioxide to improve the taste thereof |
| 03/20/1996 | CN1119019A Compositions and methods for the treatment of immunomediated inflammatory disorders |
| 03/20/1996 | CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines |
| 03/16/1996 | CA2158225A1 Imidazopyridines |
| 03/13/1996 | EP0700301A1 Peptides and compounds that bind to elam-1 |
| 03/13/1996 | EP0489108B1 Use of spiperone derivatives for immunosuppression |
| 03/13/1996 | EP0438497B1 Vasopermeability-enhancing conjugates |
| 03/13/1996 | CA2144580A1 Pharmaceutical composition for use as a retinal pigment epithelial cell growth agent |
| 03/12/1996 | US5498722 Hypotensives |
| 03/07/1996 | WO1996006863A1 Agents for inducing apoptosis and applications of said agents in therapy |
| 03/07/1996 | WO1996006859A1 Trophic factors for central nervous system regeneration |
| 03/07/1996 | WO1996006606A1 Dihydro-2,3-benzodiazepine derivatives |
| 03/07/1996 | WO1996006532A1 A basic protein composition for killing or inhibiting microbial cells |
| 03/07/1996 | CA2198587A1 Trophic factors for central nervous system regeneration |
| 03/06/1996 | EP0699678A1 Crystalline form of dihydro-2,3-benzodiazepine derivative |
| 03/06/1996 | EP0699676A1 Physical form of dihidro-2,3-benzodiazepine derivative |
| 03/06/1996 | EP0699674A1 1-Aryl-2-acetylamidopentanone derivatives for use as tachykinin receptor antagonists |
| 03/06/1996 | EP0699191A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/06/1996 | EP0440670B1 Heterocyclic acetylenic amines having central nervous system activity |
| 03/06/1996 | CN1117960A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 03/05/1996 | US5496564 Suspendible composition and process for preparing the same |
| 02/29/1996 | WO1996005840A1 Methods and means for drug administration |
| 02/29/1996 | WO1996005838A2 Combined preparation for the therapy of immune diseases |
| 02/29/1996 | WO1996005828A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists |
| 02/29/1996 | DE4430128A1 Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen Combination with immunosuppressive drug, cardiovascular and cerebral effects |
| 02/29/1996 | CA2198242A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists |
| 02/28/1996 | EP0698388A1 Ophthalmic preparation for use as artificial tear |
| 02/28/1996 | EP0697868A1 Methods and compositions using optically pure (+)-zileuton |
| 02/28/1996 | EP0697863A1 Use of dihydroliponic acid as an ophthalmologic agent and for the suppression of incompatability reactions at the interfaces between implants and living body tissue |
| 02/28/1996 | EP0697858A1 Nasal drug delivery composition containing nicotine |
| 02/27/1996 | US5494901 Includes carbonic anhydrase inhibitor |
| 02/27/1996 | CA2155447A1 Substituted biphenyl isoxazole sulfonamides |
| 02/27/1996 | CA2009118C Method and composition for cleaning and disinfecting contact lenses |
| 02/22/1996 | WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 02/22/1996 | WO1996004787A1 Combined virustatic antimediator (covam) treatment of common colds |
| 02/22/1996 | CA2196203A1 Combined virustatic antimediator (covam) treatment of common colds |
| 02/21/1996 | EP0697410A1 54-substituted alkylidene 2-(N-cyanoimino)-thiazolidin-4-one derivatives, their preparation and their use as aldose reductase inhibitors |
| 02/21/1996 | EP0696917A1 Method and means for inhibiting posterior capsule opacification |
| 02/21/1996 | CN1031051C Cycloalkyl-substituted glutaramide antihypertensive agents |
| 02/20/1996 | US5492923 Drug for treating arterial hypertension and atherosclerosis |
| 02/20/1996 | US5492689 Administering simultaneously an antiviral agent and two antiinflammatory compounds; synergistic result in treatment of cold or influenza |
| 02/15/1996 | WO1996004273A1 New pyrazole derivatives as angiotensin ii antagonist |
| 02/15/1996 | WO1996004250A1 Benzimidazole derivatives having dopaminergic activity |
| 02/15/1996 | WO1996003990A1 Optic nerve health |
| 02/15/1996 | WO1996003983A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | CA2196701A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | CA2196039A1 Optic nerve health |
| 02/15/1996 | CA2173258A1 New pyrazole derivatives as angiotensin ii antagonist |
| 02/14/1996 | EP0696452A1 Nanoemulsion of the oil in water type, useful as an ophthalmic vehicle and process for the preparation thereof |